539872 — Bajaj Healthcare Income Statement
0.000.00%
Last trade - 00:00
- IN₹8.68bn
- IN₹12.14bn
- IN₹6.73bn
- 48
- 21
- 19
- 15
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IAS | — | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,702 | 4,100 | 6,570 | 6,799 | 6,733 |
Cost of Revenue | |||||
Gross Profit | 844 | 948 | 1,929 | 1,838 | 1,826 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,361 | 3,707 | 5,365 | 5,768 | 5,907 |
Operating Profit | 341 | 393 | 1,204 | 1,031 | 826 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 242 | 361 | 1,188 | 897 | 582 |
Provision for Income Taxes | |||||
Net Income After Taxes | 163 | 252 | 831 | 714 | 430 |
Net Income Before Extraordinary Items | |||||
Net Income | 163 | 252 | 831 | 714 | 430 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 163 | 252 | 831 | 714 | 430 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.95 | 9.14 | 30.1 | 25.9 | 15.4 |
Dividends per Share | |||||
Special Dividends per Share |